[HTML][HTML] Lipoprotein Lipidomics as a Frontier in Non-Alcoholic Fatty Liver Disease Biomarker Discovery
LV Herrera-Marcos… - … Journal of Molecular …, 2024 - pmc.ncbi.nlm.nih.gov
Non-alcoholic fatty liver disease (NAFLD) is a progressive liver disease characterized by the
build-up of fat in the liver of individuals in the absence of alcohol consumption. This …
build-up of fat in the liver of individuals in the absence of alcohol consumption. This …
Lipid Profile Paradox: Investigating Improved Lipid Levels in Diabetic Mellitus Patients with Foot Ulcer Infections—A Prospective Descriptive Study
A Ardelean, AA Neamtu, DF Balta, C Neamtu, D Goldis… - Diagnostics, 2023 - mdpi.com
Type 2 diabetes mellitus (DM) is a chronic metabolic disorder posing multifaceted
challenges to global public health. Among its numerous complications, infected diabetic foot …
challenges to global public health. Among its numerous complications, infected diabetic foot …
Blood Lipids, Lipoproteins, and Apolipoproteins With Risk of Coronary Heart Disease: A Prospective Study Among Racially Diverse Populations
Background Comprehensive blood lipoprotein profiles and their association with incident
coronary heart disease (CHD) among racially and geographically diverse populations …
coronary heart disease (CHD) among racially and geographically diverse populations …
[HTML][HTML] Genetically predicted HLA-DR+ natural killer cells as potential mediators in the lipid-coronary artery disease/calcification (CAD/CAC) causal pathway
D Qian, H Zhang, R Liu, H Ye - Frontiers in Immunology, 2024 - frontiersin.org
Background Coronary artery disease (CAD) imposes a significant global health burden,
necessitating a deeper comprehension of its genetic foundations to uncover innovative …
necessitating a deeper comprehension of its genetic foundations to uncover innovative …
[引用][C] Διαγνωστική προσέγγιση των ενδογενών μεταβολικών νοσημάτων με την χρήση της φασματοσκοπίας NMR
Ε Δουλοπούλου - 2023